These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2049236)

  • 21. Pharmacokinetics of a single oral dose of clobazam in patients with liver disease.
    Monjanel-Mouterde S; Antoni M; Bun H; Botta-Frindlund D; Gauthier A; Durand A; Cano JP
    Pharmacol Toxicol; 1994 Jun; 74(6):345-50. PubMed ID: 7937568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single dose pharmacokinetics of manidipine in hepatic impaired patients and healthy controls.
    Deroubaix X; Lins RL; Lens S; Allemon A; Jeanbaptiste B; Poli G; Acerbi D; Stockis A; Ventura P
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):386-91. PubMed ID: 9707354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of age and frailty with the pharmacokinetics and pharmacodynamics of metoclopramide.
    Wynne HA; Yelland C; Cope LH; Boddy A; Woodhouse KW; Bateman DN
    Age Ageing; 1993 Sep; 22(5):354-9. PubMed ID: 8237626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacokinetics of metoclopramide in man with observations in the dog.
    Bateman DN; Kahn C; Davies DS
    Br J Clin Pharmacol; 1980 Apr; 9(4):371-7. PubMed ID: 7378253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis.
    Silvain C; Bouquet S; Breux JP; Becq-Giraudon B; Beauchant M
    Eur J Clin Pharmacol; 1989; 37(3):261-5. PubMed ID: 2612541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of molsidomine and its active metabolite, linsidomine, in patients with liver cirrhosis.
    Spreux-Varoquaux O; Doll J; Dutot C; Grandjean N; Cordonnier P; Pays M; Andrieu J; Advenier C
    Br J Clin Pharmacol; 1991 Sep; 32(3):399-401. PubMed ID: 1777378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Furosemide absorption in patients with cirrhosis.
    Fredrick MJ; Pound DC; Hall SD; Brater DC
    Clin Pharmacol Ther; 1991 Mar; 49(3):241-7. PubMed ID: 2007318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Furosemide disposition in cirrhotic patients.
    Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
    Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic interaction between fluoxetine and metoclopramide in healthy volunteers.
    Vlase L; Leucuta A; Farcau D; Nanulescu M
    Biopharm Drug Dispos; 2006 Sep; 27(6):285-9. PubMed ID: 16770757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cimetidine clearance and bioavailability in hepatic cirrhosis.
    Sonne J; Poulsen HE; Døssing M; Larsen NE; Andreasen PB
    Clin Pharmacol Ther; 1981 Feb; 29(2):191-7. PubMed ID: 7460483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of ornidazole in patients with acute viral hepatitis, alcoholic cirrhosis, and extrahepatic cholestasis.
    Taburet AM; Attali P; Bourget P; Etienne JP; Singlas E
    Clin Pharmacol Ther; 1989 Apr; 45(4):373-9. PubMed ID: 2702794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetics of cimetidine in ascitic cirrhotics].
    Albin H; Couzigou P; Vinçon G; Péhourcq F; Fleury B; Béraud C
    Gastroenterol Clin Biol; 1983 Mar; 7(3):251-5. PubMed ID: 6852412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of erythromycin in normal and alcoholic liver disease subjects.
    Hall KW; Nightingale CH; Gibaldi M; Nelson E; Bates TR; DiSanto AR
    J Clin Pharmacol; 1982 Jul; 22(7):321-5. PubMed ID: 7107981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presystemic metabolism of meperidine to normeperidine in normal and cirrhotic subjects.
    Pond SM; Tong T; Benowitz NL; Jacob P; Rigod J
    Clin Pharmacol Ther; 1981 Aug; 30(2):183-8. PubMed ID: 7249503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of tolfenamic acid in patients with cirrhosis of the liver.
    Stenderup J; Eriksen J; Pedersen SB; Christiansen LV
    Eur J Clin Pharmacol; 1985; 28(5):573-9. PubMed ID: 3876221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex-differences in the disposition of substituted benzamides: pharmacokinetics of a gastroprokinetic agent (4-amino-5-chloro-2-[2- (methylsulfinyl) ethoxy]-N-[2-(diethylamino)ethyl] benzamide hydrochloride) (ML-1035) in male and female New Zealand white rabbits.
    Rao N; Otis KW; Hwang KK
    Biopharm Drug Dispos; 1992 Dec; 13(9):681-91. PubMed ID: 1467455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colchicine clearance is impaired in alcoholic cirrhosis.
    Leighton JA; Bay MK; Maldonado AL; Schenker S; Speeg KV
    Hepatology; 1991 Dec; 14(6):1013-5. PubMed ID: 1959847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of glafenine and glafenic acid in patients with cirrhosis, compared to healthy volunteers.
    Vermerie N; Kusielewicz D; Tod M; Nicolas P; Perret G; Fauvelle F; Petitjean O
    Fundam Clin Pharmacol; 1992; 6(4-5):197-203. PubMed ID: 1358775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of chlormethiazole in healthy volunteers and patients with cirrhosis of the liver.
    Pentikäinen PJ; Neuvonen PJ; Jostell KG
    Eur J Clin Pharmacol; 1980 Apr; 17(4):275-84. PubMed ID: 6995129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.